Recombinant poliovirus for cancer immunotherapy

Affiliations

¹ Research Institute of Oncology (IPON)/Discipline of Gynecology and Obstetrics, Uberaba, Brazil.
² Research Institute of Oncology (IPON)/Discipline of Immunology, Uberaba, Brazil.

Editorial

Millena Prata Jammal et al. Ann Transl Med. 2018 Sep.

. 2018 Sep;6(18):368.

doi: 10.21037/atm.2018.07.19.

¹ Research Institute of Oncology (IPON)/Discipline of Gynecology and Obstetrics, Uberaba, Brazil.
² Research Institute of Oncology (IPON)/Discipline of Immunology, Uberaba, Brazil.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.
Brown MC, Holl EK, Boczkowski D, Dobrikova E, Mosaheb M, Chandramohan V, Bigner DD, Gromeier M, Nair SK. Brown MC, et al. Sci Transl Med. 2017 Sep 20;9(408):eaan4220. doi: 10.1126/scitranslmed.aan4220. Sci Transl Med. 2017. PMID: 28931654 Free PMC article.

1. Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015;348:62-8. 10.1126/science.aaa4967 - DOI - PMC - PubMed
1. Brown MC, Holl EK, Boczkowski D, et al. Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs. Sci Transl Med 2017;9. - PMC - PubMed
1. Brown MC, Gromeier M. Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus. Curr Opin Virol 2015;13:81-5. 10.1016/j.coviro.2015.05.007 - DOI - PMC - PubMed
1. Gromeier M, Nair SK. Recombinant Poliovirus for Cancer Immunotherapy. Annu Rev Med 2018;69:289-99. 10.1146/annurev-med-050715-104655 - DOI - PMC - PubMed
1. Hoster HA, Zanes RP, Jr, von Haam E. The association of “viral” hepatitis and Hodgkin's disease. Cancer Res 1949;9:473-80. - PubMed